Norbert E. Kaminski

Cannabinol-mediated inhibition of nuclear factor-kappaB, cAMP response element-binding protein, and interleukin-2 secretion by activated thymocytes.

N. Kaminski, A. Herring, Norbert E. Kaminski, 1999, The Journal of pharmacology and experimental therapeutics.

Attenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor- kappa B/Rel activation.

Y. Jeon, N. Kaminski, J. Pulaski, 1996, Molecular pharmacology.

Inhibition of the cAMP signaling cascade via cannabinoid receptors: a putative mechanism of immune modulation by cannabinoid compounds.

N. Kaminski, Norbert E. Kaminski, 1998, Toxicology letters.

Induction of liver-associated transforming growth factor beta 1 (TGF-beta 1) mRNA expression by carbon tetrachloride leads to the inhibition of T helper 2 cell-associated lymphokines.

Y. Jeon, N. Kaminski, K. Yang, 1997, Toxicology and applied pharmacology.

Immune regulation by cannabinoid compounds through the inhibition of the cyclic AMP signaling cascade and altered gene expression.

N. Kaminski, Norbert E. Kaminski, 1996, Biochemical pharmacology.

Examination of the immunosuppressive effect of delta9-tetrahydrocannabinol in streptozotocin-induced autoimmune diabetes.

N. Kaminski, X. Li, L. J. Fischer, 2001, International immunopharmacology.

Inhibition of the cyclic AMP signaling cascade and nuclear factor binding to CRE and kappaB elements by cannabinol, a minimally CNS-active cannabinoid.

N. Kaminski, A. Herring, W. Koh, 1998, Biochemical pharmacology.